Biocon to see block deals, as Viatris plans to exit

Biocon block deal today: Mylan may sell Rs 3,481 crore worth of shares in pharma major

According to Business Today sources, the floor price has been set at Rs 378.50 per share, a 7.9 per cent discount to Biocon's Monday closing

Biocon share price climbs 5% after block deals on NSE, BSE; key details

Biocon stock rose 4.96 per cent to Rs 430.95 apiece after sources had earlier indicated that the floor price for the block deal was set at R

Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows

SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Ind

Biocon shares jump 6% on reports of ₹3,481-crore block deal; Mylan likely to exit after 17 years

Biocon Shares Rise After Mylan Exits Following Rs. 3,676-Crore Stake Sale

Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent” or the "Company”) (Nasdaq: CBIO), a clinical-stage bi